Point72 (DIFC)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Point72 (DIFC)’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21	Closed	-$11	–	2160
2024 Q4	$11	Sell	21 -7	-25%	-$5	﹤0.01%	1471
2024 Q3	$49	Sell	28 -23,670	-100%	-$33K	﹤0.01%	1372
2024 Q2	$27.7K	Buy	+23,698	New	+$59.3K	﹤0.01%	1183

Point72 (DIFC)'s MRNS Position: Q1 2025 in Review

Point72 (DIFC) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 21 shares — an estimated $11 sold.

Point72 (DIFC) first reported a position in MRNS in Q2 2024 and held it in 3 quarters. The position peaked at $27.7K in Q2 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Point72 (DIFC) reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Point72 (DIFC) sold 21 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $11.
Point72 (DIFC) first reported a position in Marinus Pharmaceuticals, Inc in Q2 2024 and held it in 3 quarters.
Point72 (DIFC)'s Marinus Pharmaceuticals, Inc position peaked at $27.7K in Q2 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Point72 (DIFC)'s 13F filing for Q1 2025, filed 15 May 2025.